Localized Biologic Modalities for Cancer Treatment

We are thrilled to present Dr. Sean McCarthy, CEO & Chairman of CytomX Therapeutics, in our CEO webinar series moderated by Marc Estigarribia, Managing Director of MSQ Ventures. Co-hosted by MSQ Ventures and BioAroundWorld, don’t miss out on the breakdown into the advancements of CytomX Therapeutics novel Probody therapeutic platform, clinical-stage programs, and business strategies! 
 
Dr. Sean McCarthy, CEO of CytomX Therapeutic, has been driving the company’s success since 2010. Starting as Chief Business Officer, his prior roles included leadership at SGX Pharmaceuticals and Millennium Pharmaceuticals. He holds an impressive educational background, including a B.S. from King’s College, University of London, an M.B.A. from UCSD, and a DPhil from the University of Oxford. With extensive peer-reviewed publications and patents, he contributes to the boards of OncoResponse, Inc. and California Life Sciences. 

Guest Speaker: Dr. Sean McCarthy, the CEO and Chairman of CytomX Therapeutics
Moderator: Marc Estigarribia, Managing Director, MSQ Ventures   
Date: Wednesday, September 6th, 2023 
Time: 9pm – 10pm BJT / 9am – 10am ET 

Can’t attend live? Register anyway, and we’ll send you the session recording after the event. Following the webinar, attendees will also have the chance to schedule a one-on-one session with BiOneCure through MSQ.